Download Program

May 20, 2025

7:30 Arrival and Registration

7:45 Opening of the course, welcome, introduction | Amir Seyedmousavi & Darius Armstrong-James

Session 1. Chair: Masoud Mardani, Flavio De Queiroz Telles Filho 

8:00 Lecture 1. | Fungal and diseases (including Microsporidia and PJP) in normal and abnormal hosts and underlying risk factors

Ilan Schwartz (USA) 

8:20 Lecture 2 | Diagnostic mycology in practice, fungal nomenclature, emerging fungal pathogens

Amir Seyedmousavi (USA) 

8:40 Lecture 3 | Early diagnosis of aspergillosis and rare molds (Fusarium Scedosporium)

Juan Gea-Banacloche (USA) 

9:00 Lecture 4 | Diagnosis of Candidiasis and rare yeasts

Maiken Arendrup (Denmark) 

9:20 Lecture 5 | Routine Mycology Laboratory Workups (Yeast vs. Molds, Diagnostics vs. Surveillance)

Hein van der Lee (Netherlands) 

9:40 Q &A

9:55-10:10 Comfort Break

Session 2. Chairs: Mohammad Hedayati, Nicolas Barros 

10:10 Lecture 6. | Diagnosis of Mucorales and Melanized fungi

Shivaprakash Rudramurthy (India) 

10:30 Lecture 7 | Diagnosis of Cryptococcosis and Pneumocystosis

Zeynab Yassin (Iran) 

10:50 Lecture 8 | Diagnosis of Coccidioidomycoses and Endemic Dimorphs

Nicolas Barros (USA) 

11:10 Lecture 9 | Antifungals in clinical Practice and importance of resistance detection

Masoud Mardani (Iran) 

11:30 Lecture 10 | Point of care diagnostic assays 

Darius Armstrong-James (UK) 

11:50 Q & A

Session 3. Chairs: Amir Seyedmousavi (USA) & Darius Armstrong-James (UK)

- 12:00-12:30: General Assembly Meeting of Fungal Diagnostics Working Group and Selection of Board Members for 2025-2028

 Day 2: December 5, 2024

08:00–08:30 Welcome & Refreshments 

Session 5. Chairs: Mihalis Lionakis, John Perfect

• 08:30–08:55 Case study 5: Antifungal host defenses. Steven Holland
• 08:55–09:20 Antifungals and their mechanisms of action: currently available and new antifungal drugs. Mihalis Lionakis
• 09:20–09:45 Antifungal susceptibility testing (EUCAST versus CLSI). Nathan Wiederhold
• 09:45–10:10 Mechanism of antifungal resistance in yeasts and currently available phenotypic and genotyping laboratory assays. Mahmoud Ghannoum
• 10:10–10:35 Mechanism of antifungal resistance in molds and currently available phenotypic and genotyping laboratory assays. Paul Verweij
• 10:35–10:50 Q&A

10:50–11:10 Comfort Break

Session 6: Chairs: Juan Gea-Banacloche, Riina Richardson  

• 11:10–11:35  Case study 6: Fungal diagnostic assays that clinicians need in resource-limited countries. Rita Oladele 
• 11:35–12:00 Testing for Candida auris colonization screening. Philippe Dufresne
• 12:00–12:25 Infection prevention for zoonotic dimorphs and other emerging fungal disease. Flavio Queiroz Telles
• 12:25–12:40 Q&A

12:40–13:30 Lunch 

Session 7. Chairs: Flavio De Queiroz Telles Filho, Kieren Marr

• 13:30–13:55 Case study 7: A clinician’s view of point of care diagnostics for invasive mold disease: promises, challenges, and prospects. Dimitrios Kontoyiannis
• 13:55–14:20 Serodiagnosis of histoplasmosis, blastomycosis and coccidioides infection. Joe Wheat
• 14:20– 14:45 non-culture-based diagnosis of Aspergillus vs. Candida infections. Martin Hönigl
• 14:45–15:10 Cryptococcosis antigen detection. Amir Seyedmousavi
• 15:10–15:25 Q&A 

15:25 – 15:45 Comfort Break

 Session 8. Chairs: Arunaloke Chakrabarti, Darius Armstrong-James

• 15:45–16:10 Case study 8: Fungal cell-free DNA (cfDNA) detection. Niaz Banaei
• 16:10–16:35 Non-invasive surrogate markers under development. Kieren Marr
• 16:35–16:50 Q&A 

16:50–18:00 Closing Remarks and Certification Ceremony. Amir Seyedmousavi, Malcolm Richardson

ISHAM-Fungal Dx 2024 will start at 8.00 AM on Wednesday 4 December 2024 and will end on Thursday 5 December 2024 at 6.00 PM. 

 The workshop language will be English.